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Abstract
The dysfunction of parvalbumin-positive, fast-spiking interneurons (FSI) is considered a primary contributor to the
pathophysiology of schizophrenia (SZ), but deficits in FSI physiology have not been explicitly characterized. We show for the
first time, that a widely-employed model of schizophrenia minimizes first spike latency and increases GluN2B-mediated
current in neocortical FSIs. The reduction in FSI first-spike latency coincides with reduced expression of the Kv1.1 potassium
channel subunit which provides a biophysical explanation for the abnormal spiking behavior. Similarly, the increase in
NMDA current coincides with enhanced expression of the GluN2B NMDA receptor subunit, specifically in FSIs. In this study
mice were treated with the NMDA receptor antagonist, MK-801, during the first week of life. During adolescence, we
detected reduced spike latency and increased GluN2B-mediated NMDA current in FSIs, which suggests transient disruption
of NMDA signaling during neonatal development exerts lasting changes in the cellular and synaptic physiology of
neocortical FSIs. Overall, we propose these physiological disturbances represent a general impairment to the physiological
maturation of FSIs which may contribute to schizophrenia-like behaviors produced by this model.
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healthy humans that are highly reminiscent of psychosis in SZ
patients [14] [15]. Moreover, these drugs elicit behavioral deficits
in animal models that closely model aspects of SZ [16]; [17] and
also replicate disruptions in GABAergic biochemical markers.
Administration of non-competitive NMDA receptor antagonist
during early development is a particularly robust approach to
model SZ-like biochemical deficits to GABA signaling [18–23].
Electrophysiological characterization of the NMDA hypofunction
model of SZ has recently begun [24], but remains incomplete.
Since direct physiological evaluation of FSIs in SZ patients is
unfeasible, electrophysiological characterization of FSIs in animal
models of SZ may be an expedient approach to identify specific
impairments in FSI function.
In this study neonatal mice were treated with the NMDA
receptor antagonist, MK-801, on postnatal day (PND) 6–8. The
impact of neonatal MK-801 treatment on FSI physiology was then
assessed during adolescence. This approach allowed us to directly
test the hypothesis that transient disruption of NMDA receptor
activity during early development causes persistent impairments to
the function of neocortical FSIs. Whole-cell patch-clamp electrophysiology revealed that neonatal MK-801 treatment dramatically
altered the spiking kinetics and action potential dynamics of FSIs.

Introduction
Deficits to inhibitory neurotransmission are highly implicated in
the etiology of schizophrenia (SZ) [1], as immunohistochemical
analyses of post-mortem brain tissue often reveal decreases in the
expression of one or more biochemical markers for gammaaminobutyric acid (GABA) signaling [1]. Expression of the calcium
binding protein, parvalbumin (PV), is particularly diminished in
the neocortex of many SZ patients [2], which implies dysfunction
of PV-expressing interneurons [3]. PV-expressing interneurons are
physiologically distinguished by their capacity to discharge action
potentials (‘‘spikes’’) at very high frequency and are thus termed
‘‘fast spiking’’ interneurons [4]. FSIs are interconnected via
chemical and electrical synapses [5–7] which helps synchronize
their own firing patterns [8,9], and pace the firing patterns of large
networks of pyramidal cells [10]. FSIs are thus integral for
generating neural oscillations [11,12], which incidentally, are often
compromised in SZ patients. Although FSI dysfunction is highly
inferred in the pathophysiology of SZ [13], physiological support
for this hypothesis is lacking, particularly at the single cell level.
The NMDA receptor hypofunction model of SZ is founded on
the discovery that acute administration of non-competitive NMDA
antagonist (e.g. PCP, ketamine, and MK-801) evokes behaviors in
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Pharmacological analysis revealed an increase in GluN2Bmediated NMDA current at excitatory synapses of FSIs from
MK-801-treated mice. Immunohistochemical analyses identified
congruent changes in the expression of key ion channel subunits
that corroborate both sets of physiological data.

Preparation of Brain Slices for Electrophysiology
Three to six week-old mice were anesthetized by carbon dioxide
exposure and decapitated (N = 9, from 4 litters (vehicle-treated);
N = 13, from 5 litters (MK-801-treated). Brains were rapidly
removed to ice-cold, oxygenated (95% O2/5% CO2) sucrosebased slicing solution (in mM): 234 sucrose, 11 glucose, 24
NaHCO3, 2.5 KCl, 1.25 NaH2PO4*H2O, 10 MgSO4 and 0.5
CaCl2. Brains were trimmed, glued to a stage, and immersed in
cold slicing solution. The somatosensory cortex (S1) was cut into
300 uM thick coronal slices with a vibrating microtome (Leica
1200S, Germany) and transferred to an incubation chamber
containing oxygen-saturated artificial cerebral spinal fluid (aCSF)
comprised of (in mM): 126 NaCl, 26 NaHCO3, 10 glucose, 2.5
KCl, 1.25 NaH2PO4*H2O, 2 MgCl2*6H2O, and 2 CaCl2*2H2O;
pH 7.4. Modified coronal slices were used in a subset of
experiments to retain a complete thalamocortical circuit [27,28].
Slices were incubated at 32uC for one hour, then placed at
ambient temperature (21–23uC) for 30 minutes prior to recording.
Brain slices were placed into a recording chamber and visualized
with a fixed staged, upright microscope (Nikon, FN1) equipped
with 4x and 60x objectives, fluorescent filters, infrared (IR)
illumination, Nomarski optics, and an IR-sensitive video camera
(Cool Snap EZ, Photometrics).

Methods and Materials
Experimental Animals
Ethics Statement. All animal use procedures were carried
out in strict accordance with National Institutes of Health Guide
for the Care and Use of Laboratory Animals and were approved
by the Institutional Animal Care and Use Committee at
Children’s National Medical Center.
To aid visualization of FSIs, we utilized transgenic mice that
expressed the fluorescent reporter, Enhanced Yellow Fluorescent
Protein (EYFP), exclusively in PV+ interneurons. These PV-Cre+/
2
; Rosa26EYFPloxP+ mice were obtained by crossing a transgenic
strain expressing cre recombinase under the control of the
endogenous parvalbumin promoter (PV-cre); and a strain
expressing a loxP-flanked Rosa26-EYFP marker (Jackson Laboratories, Maine). Only male mice were used in this study as
sexually dimorphic responses to MK-801 have been reported
[25,26]. Male mouse pups were randomly assigned to the control
or experimental group on PND6 and administered a subcutaneous
injection of 0.75 mg/kg MK-801 (Tocris, USA) or an equal
volume of saline for three consecutive days.

Electrophysiological recordings
Whole-cell patch-clamp recordings of FSIs were obtained under
continuous perfusion of oxygenated aCSF (,2 ml/min). Non-

Figure 1. Postnatal NMDA receptor blockade decreases first-spike latency in neocortical layer IV FSIs. (A, B) Prototypical discharge
patterns of FSIs from a vehicle- or MK-801-treated mouse. Traces show voltage response to 600 ms injections of current at saturating (black trace), or
threshold (red trace) amplitude. Red arrows below trace indicate onset of current injection and spike threshold (defined as dVm/dt.10). Solid red bar
below trace illustrates delay to first spike (C) Quantification of delay to first spike at rheobase response. Values are means 6 S.E.M. *P,0.05, vs.
control. (D, E). A log-log plot of first spike delay versus amplitude of injected current in layer IV FSIs from vehicle- (D) or MK-801–treated mice (E).
Dashed lines on the y-axes illustrate spike latency of log 0.3 ms (or 2.0 ms log10).
doi:10.1371/journal.pone.0109303.g001
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Table 1. Electrical properties of layer IV FS neurons in the Somatosensory Cortex.

Vehicle-Treated

MK-801-Treated

Passive Intrinisic Properties
Rin (MV)

103.068.1 (9)

154.8613.4** (13)

Vrest (mV)

265.561.8 (9)

266.961.1 (13)

tm (ms)

6.860.8 (9)

8.560.8 (11)

Ih (mV)

4.0060.5 (7)

3.7560.9 (7)

Active Intrinsic Properties
Ith (pA)

190645 (9)

140620 (13)

Max. Spike Freq. (Hz)

161.869.9 (9)

138.7616.9 (9)

AP half-width (ms)

0.4160.02 (9)

0.4760.01** (13)

AP accommodation ratio

0.9460.10 (9)

0.7360.02* (13)

AP threshold (mV)

241.963.2 (9)

234.066.5 (13)

AHP Amplitude (mV)

17.162.5 (9)

15.561.3 (13)

Ratio 1st/2nd AHP Amp.

1.0260.01 (9)

1.0160.003 (13)

tAHP

3.4160.08 (9)

3.6360.34 (12)

peak

(ms)

*P,0.05;
**P,0.01.
Vrest, resting membrane potential; Rin, input resistance; tm, membrane time constant. Data are mean 6 SEM. Numbers in parantheses are N.Selected values shown in
bold are significantly different from the same parameter measured in control cells.
*Value is significantly (P,0.05) different from control.
**Value is significantly (P,0.01) different from control.
Resting membrane potential (Vrest) was recorded within the first two minutes after break in. Input resistance (Rin) was calculated from the voltage response measured
at the end of hyperpolarizing current steps (600 ms). Membrane time constant (t) was obtained by fitting a single exponential to the relaxation of membrane potential
(Vm) to a 2300 pA current injection. Ih current was calculated by the formula Vm22Vm1, where Vm2 was measured at the end of a 2300 pA current step and Vm1 was
measured at the maximal hyperpolarization. Depolarizing currents were injected to elicit action potentials (AP) and the AP firing patterns were used to characterize
accommodation ratio, APl duration at half-width, AP amplitude and rise time. Single AP properties were measured from the first AP elicited by a minimally suprathreshold current step which elicited a continuous train of APs. AP firing threshold was determined by differentiating the voltage trace (dV/dt) evoked by the current
step in current-clamp mode. The voltage and time at which the first AP discharged were taken as the value at which dV/dt$10. In all recordings, this value exceeded
baseline values (an average of the preceding 10–100 ms) by$20-fold. AP half-width was defined as the period between the half-amplitude point in the rising and
decaying phase of the AP. The ratio of the 1st AP/2nd AP was calculated using the peak amplitudes as one measure of accommodation. The ratio of the interval
between the first APs and the average interval of the last three APs during a train was calculated as a second measure of AP accommodation. The after
hyperpolarization (AHP) amplitude was calculated as the difference from AP threshold to the maximum trough of hyperpolarization.
doi:10.1371/journal.pone.0109303.t001

the study. Phase plots were constructed by calculating the first
derivative (dV/dt) of Ith and plotting the value versus membrane
potential (Vm).
For evoked recordings, depolarizing current pulses were
delivered once every 15 seconds (Isoflex, A.M.P.I.; CPI, Carl
Pisaturo, Stanford University). A minimal stimulation protocol was
used to evoke EPSCs with a failure rate of approximately 50%.
The amplitude of the current pulse ranged from 8.8–150 mA, with
a fixed duration of 0.2 ms. EPSCs were evoked at the
thalamocortical synapses of layer IV FSIs by placing a 25 mm
concentric bipolar microelectrode (FHC, Bowdoin, ME) directly in
contact with fibers projecting from the ventrobasal complex of the
thalamus. EPSC amplitude was measured from the baseline to the
peak of the initial response. The averaged EPSC decay time was fit
to the double exponential function: e(t) = A1exp2t/t1+A2exp2t/t2.
These fits were used to determine a weighted time constant:
tW = (t1a1+t2a2)/(a1+a2) where a and t is the amplitude and time
constant, respectively. NMDA currents were pharmacologically
isolated by adding 20 uM glycine (Sigma), 20 uM 6,7-Dinitroquinoxaline-2,3-dione (DNQX, Tocris) and 10 uM SR 95531
hydrobromide (Gabazine, Tocris) to the perfusate.

filamented glass pipettes (King Precision Glass, USA) were pulled
on a vertical puller (PC-10, Narishige) to obtain electrodes with
resistances of 3–5 MV when filled with an intracellular solution (in
mM): 70 KCl, 70 potassium gluconate, 10 HEPES, 10 EGTA,
2 MgCl2, 4 Mg-ATP, 0.3 Na-GTP. Spontaneous excitatory and
inhibitory events were acquired using a cesium-based intracellular
solution comprised of (in mM): 20 KCl, 100 cessium methanesulfonate, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 3 QX-314 [29].
A GV seal was formed between the cell and glass pipette and a
solenoid-controlled vacuum transducer was used to apply brief
suction pulses (120 psi at 20–50 ms) to break into the cell.
Recordings were acquired with pClamp 10 and a MultiClamp
700B amplifier (Molecular Devices, Sunnyvale, CA). Capacitance
and series resistance compensation were used (typically 80%), and
series resistance was continuously monitored throughout experiments. Putative FSIs were visually identified by EYFP fluorescence
and then biophysical responses to brief hyperpolarizing and
depolarizing current injections were characterized to confirm
identity. The rheobase current (Ith) was determined as the
minimum current amplitude capable of discharging a single spike
for three consecutive trials. To accurately measure Ith, the
amplitude of injected current was incrementally increased by 1–
5 pA per sweep. Most cells discharged a single spike at Ith, (9/
10 cells recorded in 10 slices from 9 vehicle-treated animals; 13/
17 cells recorded in 17 slices from 13 MK-801-treated animals).
Any cell which did not discharge a single spike was omitted from
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Clampfit v10.2 (Molecular Devices, Sunnyvale CA) and Mini
Analysis Program (Syanptosoft, Decatur, GA).
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Figure 2. Postnatal NMDA receptor blockade destabilizes spike threshold in neocortical layer IV FSIs. (A, B) Representative voltage
responses of first spikes elicited from FSIs at rheobase (Ith); Ith+100 pA; Ith+200; and Ith+300 pA current steps. For clarity, only the initial spike in each
trace is displayed, and the intervening, +50 pA, current steps are omitted. (C, D) Phase plots of the traces shown in A, B. Phase plots are shown for the
first spike discharged during injection at Ith and Ith +: 50, 100, 150, 200, 250 and 300 pA. (E, F) Regions of interest indicated by the dashed line are
displayed at higher magnification. Red dashed line indicates spike threshold (dV/dt = 10). Insets are plots of injected current amplitude versus first
spike threshold of displayed cell. (G, H) Plots of injected current amplitude versus first spike threshold. (I) Mean slope of injected current amplitude
versus first spike threshold in (G, H). Values are means 6 S.E.M. **P,0.005, vs. control by ANOVA.
doi:10.1371/journal.pone.0109303.g002

PLOS ONE | www.plosone.org

4

October 2014 | Volume 9 | Issue 10 | e109303

Transient NMDA Blockade Disrupts Interneuron Function

Figure 3. Postnatal NMDA receptor blockade reduces somatic expression of Kv1.1. (A–H) Representative confocal micrographs (maximal
intensity, flattened Z-stack, z separation of 1.03 um) of somatosensory cortex from adolescent mice (PND42) neonatally injected with vehicle (A–D), or
MK-801 (E–H). (D, H) Staining for the Kv1.1 potassium channel subunit is dramatically reduced in FSIs from MK-801-injected mice. Insets in (B) and (F)
show higher magnification of layer IV regions of interest. Green = Parvalbumin; Red = Kv1.1. Scale bars = 100 um (A–C; E–G) or 10 um (D, H and insets
in B, F).
doi:10.1371/journal.pone.0109303.g003

Results

Immunohistochemistry
Mice were anesthetized with isoflurane. An incision was made
into the thoracic cavity, the rib cage was removed and mice were
transcardially perfused with 20 mL of ice cold phosphate buffered
saline (PBS) followed by 20 mL of an ice cold 4% paraformaldehyde (PFA) solution. The brain was removed and fixed overnight
in 4% PFA. Brains were immersed in agar and cut into coronal
sections (50 uM). Primary antibody staining was performed by
incubating free-floating sections in a solution of PBST (PBS+0.2%
Tween) +10% normal goat serum with the one or more of the
following antibodies: mouse, anti-parvalbumin (Sigma, St. Louis,
MO); goat, anti-NR2B (Abcam, Cambridge, MA); rabbit antiparvalbumin (Savant, Switzerland); and mouse Kv1.1 (UC Davis/
NIH NeuroMab Facility). Sections were shaken overnight at 4uC,
then washed five times in PBST and incubated overnight at 4uC in
a solution of PBST+10% normal donkey serum and the following
secondary antibodies: donkey, anti-rabbit Alexa 488 (Invitrogen);
donkey, anti-mouse Alexa 555 or donkey anti-goat Alexa 555.
Sections were washed, mounted, and covered with a glass cover
slip. Confocal micrographs were captured on a Leica LSM 510
confocal microscope equipped with 10x, 20x, 40x oil, 63x oil, and
100x oil objectives. Post-hoc immunohistochemical analysis
confirmed all fluorescently labeled cells were positive for
parvalbumin.

Neonatal NMDA Receptor Blockade Minimizes First-Spike
Latency in Neocortical FSIs
The electrophysiological development of FSIs in the mouse
somatosensory cortex (S1) has been comprehensively characterized [30], and FSIs from S1 may also be highly vulnerable to
perinatal NMDA receptor blockade [18]. We therefore chose FSIs
from S1 as the subject of this study to maximize sensitivity to MK801 treatment.
The onset of action potential discharge (or ‘‘spiking’’) varies
widely in neocortical FSIs and is inversely proportional to stimulus
strength [31]. Strong stimuli elicit spikes from FSIs rapidly,
whereas near-threshold level stimuli elicit spikes with a temporal
delay, termed first-spike latency [31]. We found that first-spike
latency was significantly shorter in FSIs from MK-801-treated
mice compared to vehicle-treated mice [MK-801-treated:
12.561.7 ms (SEM), n = 11 cells; versus Vehicle-treated:
43.8617.0 ms, n = 9 cells; P = 0.02] (Figures 1A, B). Since firstspike latency is inversely proportional to stimulus intensity, we
examined the relation of stimulus intensity to first-spike latency to
more closely assess the impact of neonatal MK-801 treatment on
the input-output function of FSIs. A log-log plot confirmed firstspike latency is, indeed, inversely proportional to stimulus intensity
when spikes are discharged by low-to-moderate strength stimuli
(e.g. current amplitude of ,2x Ith) (Figure 1D). However, when
spikes were discharged by high intensity stimuli (e.g. .2x of Ith),
the relation of stimulus intensity to first-spike latency became nonlinear and a stable, stimulus-insensitive function appeared in FSIs
from saline-treated mice (Figure 1D). By contrast, first-spike
latency in FSIs from MK-801 treated mice remained inversely
proportional at all stimulus intensities (Figure 1E). This permitted
spikes with substantially shorter latencies to be discharged by high

Statistical Analysis
Data are expressed as mean +/2 SEM. Differences among
experimental groups were considered statistically significant at p,
.05. ANOVA and two-tailed, Student’s T-Test was used to
compare changes between each experimental group.
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Figure 4. Postnatal NMDA receptor blockade increases glutamatergic input to neocortical FSIs. (A) Representative whole-cell patch
clamp recordings from FSIs in acute brain slices from the somatosensory cortex of adolescent mice (PND21-P25) neonatally-treated with vehicle or
MK-801. Spontaneous activity was recorded in 2 mM (left traces) or 0 mM (right traces) of added Mg2+. Recordings were obtained in voltage clamp
mode. sIPSCs (top traces) were recorded at the sEPSC reversal potential (,+10 mV) and sEPSCs (bottom traces) were recorded at the Cl- reversal
potential (,240 mV). (B) Bar graphs of mean sEPSCs and sIPSCs frequency obtained during 5 min recordings. Values are means 6 S.E.M. *P,0.05, vs.
control by ANOVA.
doi:10.1371/journal.pone.0109303.g004

characterized several active and passive membrane properties of
FSIs to determine the impact of neonatal MK-801 treatment. The
input resistance of FSIs from MK-801 treated mice was 50.3%
higher than vehicle-treated mice [Rin; MK-801-treated:
154.8613.4 MV
(SEM),
n = 13;
Vehicle-treated:
103.068.1 MV. n = 9; P,0.01, Table 1]. Spikes discharged from
the FSIs of MK-801-treated mice were 14.6% broader than
vehicle-treated mice [AP K width: MK-801-treated:
0.4760.01 ms (SEM), n = 13; Vehicle-treated: 0.4160.02 ms,
n = 9; P,0.01, Table 1] and displayed significantly more spike
frequency accommodation [spike frequency accommodation ratio:
MK-801-treated: 0.7360.02 ms (SEM), n = 13; Vehicle-treated:
0.9460.10 ms, n = 9; P,0.05, Table 1]. The maximum firing
rate of FSIs from MK-801-treated mice was 17% lower than FSIs

intensity stimulation. These data suggest first-spike latency is
comprised of at least two components in FSIs which exhibit
distinct relationships to stimulus intensity. Moreover, neonatal
NMDA receptor blockade appears to shorten the stimulusinsensitive component of first-spike latency.

Neonatal NMDA Receptor Blockade Alters Several
Intrinsic Spiking Properties of Neocortical FSIs
Many intrinsic properties of FSIs are optimized to deliver
precisely timed spikes [32] that exhibit very little frequency
accommodation during spike trains [4]. For instance, FSIs exhibit
a low input resistance, fast membrane time constant, and narrow
spike width [33]. All of these attributes help FSIs discharge spikes
with high temporal precision and at a sustained rate. We
PLOS ONE | www.plosone.org

6

October 2014 | Volume 9 | Issue 10 | e109303

Transient NMDA Blockade Disrupts Interneuron Function

Figure 5. Postnatal NMDA receptor blockade increases expression of functional NR2B receptors in neocortical FSIs. Prototypical
excitatory post-synaptic currents were evoked onto layer IV FSIs in a thalamocortical slice preparation. (A–C) AMPA-mediated responses were similar
in vehicle-treated mice (black traces) and MK-801-treated mice (red traces). (VHold-AMPA = 260 mV). Traces shown are the average of 5–10 responses
obtained at the same stimulus intensity from vehicle-treated mouse (black lines); or MK-801-treated mouse (red lines). Dashed boxes designate
regions of interest in activation and decay kinetics. (D–F) Bar graphs of mean current amplitude and mean weighted activation tau (twAct.) and
deactivation tau (twDeact.) of evoked AMPA current evoked from vehicle-treated mice (black bars) and MK-801-treated mice (red bars). (G, H) The
kinetics of NMDA-mediated responses are slower in MK-801-treated mice (red traces). (VHold-NMDA = +60 mV). Traces shown are the average of 5–10
responses obtained at the same stimulus intensity. Dashed boxes designate regions of interest in activation and decay kinetics. (I–K) Bar graphs of
mean current amplitude and mean weighted activation tau (tw) and deactivation tau (tw) of evoked NMDA current from vehicle and MK-801-treated
mice. Values are means 6 S.E.M. *P,0.05, vs. control by ANOVA. (L–S) Representative confocal micrographs of layer IV somatosensory cortex from
mice neonatally treated with vehicle (L–O), or MK-801 (P–S). (L, P) Dashed boxes designate regions of interest in layer IV selected for higher
magnification as shown in (M–O), and (Q–S). Green = Parvalbumin; Red = GluN2B. Scale bars = 100 um (L, P) or 10 um (M–O; Q–S). Images are shown
as a maximum intensity projection of single images at a Z-spacing of 1.0 uM. (N, R) Arrowheads denote GluN2B staining as puncta or broad staining
in brain slices from a vehicle-treated, or MK-801-treated mouse, respectively. (T–W) Representative traces of ifenprodil blockade on monosynaptic
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NMDA current evoked onto a FSI from an adolescent mouse neonatally treated with vehicle (T) or MK-801 (V) Traces shown are averages of 5–10
responses to the same stimulus intensity before (black lines) and after (grey lines) 10 minute wash in of 3 uM Ifenprodil. (U, W) Same traces as shown
in (T) and (V) scaled on y-axis to facilitate visual comparison of the actions of ifenprodil on activation and decay kinetics. Average traces were fit, as
previously described. (X, Y, Z) Quantitative analysis of impact of ifenprodil on mean peak amplitude (X); mean reduction in total charge (Y); and mean
change in tw decay (Z). (N = 4 cells from 4 animals (vehicle-treated); and 3 cells from 3 animals (MK-801-treated).
doi:10.1371/journal.pone.0109303.g005

channel subunits [34]. In neocortical FSIs, first-spike latency is
specifically mediated by the Kv1.1 subunit [31]. We therefore
hypothesized the alterations in first-spike latency and spike
threshold dynamics observed in FSIs from MK-801-treated mice
resulted from disturbances in the expression of the Kv1.1 subunit.
Immunohistochemical analysis revealed that neonatal MK-801
treatment dramatically reduced staining for the Kv1.1 subunit in
neocortical FSIs (Figures 3A–H). These findings are consistent
with our physiological characterizations and demonstrate that
transient, NMDA receptor blockade during early development can
reduce expression of the Kv1.1 subunit in the FSIs of adolescent
mice.

from vehicle-treated mice, although this difference was not
statistically significant (P = 0.11). Together these data suggest
neonatal NMDA receptor blockade disrupts both active and
passive membrane properties of neocortical FSIs which could
subsequently impair spiking behavior.

Neonatal NMDA Receptor Blockade Destabilizes Spike
Threshold Dynamics
The spike threshold of layer IV neocortical neurons can be
dynamic [34]. We characterized the spike threshold dynamics of
neocortical FSIs to assess the impact of neonatal NMDA receptor
blockade. We first examined spike threshold at Ith. Ith was
determined, as previously described, and phase plots were
constructed for each cell to allow spike threshold to be determined
graphically (Figure 2). Spike threshold at Ith was about 8 mv more
depolarized in FSIs from MK-801-treated mice, although this
difference was not statistically significant [Vehicle-treated: 2
41.963.2, n = 9 versus MK-801-treated: 234.066.5 mV, n = 13;
P = 0.34, Table 1]. The amplitude of the Ith current was
incrementally increased in successive sweeps to examine the
dynamics of spike threshold (Figure 2C–F). The spike threshold of
FSIs from vehicle-treated mice was examined across a broad range
of stimulus intensities and found to be stable and independent of
current amplitude (Figure 2G). By contrast, FSIs from MK-801treated mice exhibited a positive correlation to current amplitude
[slope in MK-801-treated FSIs: 0.01860.004 pA mV21, n = 8;
versus slope of vehicle-treated FSIs: 20.00460.004 pA mV21,
n = 8; P = 0.003] (Figure 2I). These data suggest stimulus intensity
has a larger influence on the spike threshold of FSIs from MK801-treated mice, and that the dynamics of spike threshold are also
less stable than in FSIs from vehicle-treated mice.

We next evaluated the impact of neonatal NMDA receptor
blockade on synaptic input to FSIs. Whole-cell patch clamp
recordings from neocortical FSIs revealed the average frequency
of sEPSCs recorded from FSIs of MK-801-treated mice was 50%
higher than vehicle-treated mice, although statistical significance
was not reached [Vehicle-treated: 21.264.4 Hz, n = 6; versus
MK-801-treated: 31.462.7, n = 8; P = 0.06] (Figure 4A). NMDAmediated EPSCs may be highly sensitive to Mg2+ block [35,36], so
we repeated these experiments in superfusate with 0 mM added
Mg2+ (Figures 4A, B). In nominal Mg+, the frequency of sEPSCs
recorded from the FSIs of MK-801-treated mice was 60% higher
than sEPSCs recorded from vehicle-treated mice and statistically
significant [Vehicle-treated: 16.162.51 Hz, n = 4; versus MKTreated: 26.162.21 Hz, n = 8; P = 0.03] (Figure 4B). There was
no difference in sIPSC frequency at either concentration of Mg2+
(Figure 4B), thus inhibitory currents were not examined further.

Neonatal NMDA Receptor Blockade Reduces Kv1.1
Expression in Neocortical FSIs

Neonatal NMDA Receptor Blockade Increases NMDA
Current at the Thalamocortical Synapses of FSIs

Both first-spike latency and spike threshold are strongly
modulated by K+ channels comprised from Kv1 potassium

The increase in sEPSC frequency that occurs in 0 mM Mg2+
superfusate could result from increased NMDA-mediated events

Neonatal NMDA Receptor Blockade Increases Mg2+Sensitive sEPSCs onto FSIs

Figure 6. Schematic depiction of how neonatal MK-801 treatment impacts the spike timing of an FSI from an adolescent mouse. (A)
A significant proportion of the current injected during whole-cell patch-clamp (yellow lightning bolts) dissipates through the high density of Kv1.1containing K+ channels expressed in FSIs from vehicle-treated mice. (B) The time required to depolarize the cell membrane to threshold is increased
and first-spike latency is temporally expanded. (C) By contrast, a lower proportion of injected current dissipates FSIs from MK-801-treated mice due to
reduced expression of Kv1.1-containing K+ channels. (D) The time required to depolarize to threshold is reduced and first-spike latency is therefore
minimized.
doi:10.1371/journal.pone.0109303.g006
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or increased a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA)-mediated events. Moreover, since layer IV FSIs
receive excitatory input from both thalamocortical circuits [28,37]
and local layer IV spiny stellate cells [38] the origin of the Mg2+sensitive sEPSCs was not clear. To more clearly distinguish the
source of the Mg2+-sensitive sEPSCs we utilized a thalamocortical
slice preparation. In this preparation, monosynaptic AMPA
currents were evoked onto FSIs from vehicle-treated or MK801-treated mice (VHOLD = 260 mV). The average amplitude of
AMPA current was similar between the two groups [Vehicletreated: 97.2613.0 pA, n = 3; MK-801-treated: 87.3623.6 pA,
n = 3; P = 0.36] (Figures 5A, D), and no difference was detected in
the 10–90% rise time [Vehicle-treated: 1.860.1 ms, n = 3; MK801-treated: 2.160.7 ms, n = 3; P = 0.32] or decay time [Vehicletreated: 3.061.2 ms, n = 3; MK-801-treated: 4.861.3 ms, n = 3;
P = 0.18] of evoked AMPA current (Figures 5B, C, E, F).
Although there was no difference in the peak amplitude of
evoked NMDA current [Vehicle-treated: 131.46105.5 pA, n = 3;
MK-801-treated: 137.3665.4 pA, n = 3; P = 0.49] (Figure 5G, I),
both the 10–90% rise time and the decay time of evoked NMDA
current was significantly slower in FSIs from MK-801-treated
mice: [10–90% rise time: MK-801-treated: 37.9612.4 ms, n = 3;
Vehicle-treated: 5.261.7 ms, n = 3; P = 0.02], [Average decay
time: MK-801-treated: 170.469.7 ms, n = 3; Vehicle-treated:
54.3612.0 ms, n = 3, P = 0.02] (Figures 5G, H, J, K). Together
the increase in Mg2+-sensitive sEPSCs, and slower kinetics of the
evoked NMDA current suggests neonatal NMDA receptor
blockade alters the composition of NMDA receptors expressed
at the thalamocortical synapses of layer IV FSIs.
NMDA receptors are comprised from heteromeric subunits [39]
and the kinetic properties of the receptor channel are mostly
determined by GluN2 subunits [40]. By adolescence, neocortical
NMDA current is predominated by GluN2A and GluN2Bcomprised receptors [41]. The GluN2B subunit confers slower
channel kinetics to NMDA receptors [42], thus we hypothesized
neonatal MK-801 exposure altered expression of GluN2B subunits
in FSIs. Immunohistochemical analysis revealed neonatal MK-801
treatment increased GluN2B staining in FSIs (Figures 5R, S). The
functionality of the surplus GluN2B subunits was examined by
measuring the sensitivity of evoked NMDA current to the
GluN2B-selective antagonist, ifenprodil [43]. Bath application of
ifenprodil dramatically increased the decay rate of NMDA current
evoked onto FSIs from MK-801-treated mice, but not vehicletreated mice [% change tW: Vehicle-treated, 29.9613.7%, n = 3;
% change tW: MK-801-treated, 55.664.0%, n = 3, P = 0.008]
(Figures 5T, U, Z). Similarly, ifenprodil attenuated the peak
amplitude and total charge of NMDA current evoked from MK801-treated mice more strongly than vehicle-treated mice [% peak
amplitude reduction INMDA: Vehicle-treated, 49.561.7%, n = 3;
MK-801-treated, 80.462.4%, n = 3, P = 0.009] [% reduction
QNMDA: Vehicle-treated, 35.166.7%, n = 3; MK-801-treated,
90.161.7%, n = 3; P = 0.009] (Figures 5X, Y). These data
demonstrate neonatal MK-801 treatment substantially increased
the proportion of GluN2B-mediated NMDA current at the
thalamocortical synapses of layer IV FSIs.

Neonatal MK-801 Treatment May Minimize First-Spike
Latency by Reducing Kv1.1 Expression in FSIs
Neonatal MK-801-treatment reduces expression of the Kv1.1
subunit (Figure 3) which we propose shortens first-spike latency in
FSIs (Figure 1). First, consider that near resting membrane
potential a substantial fraction of Kv1.1-comprised K+ channels
are partially open [44]. Thus, during low amplitude stimulation a
significant portion of the current injected during whole-cell patch
clamp of FSIs leaks out as K+ ions (Figure 6A). This efflux of K+
ions slows the rate of membrane depolarization [45] [44] and
delays spike discharge [44] (Figure 6B). Since neonatal MK-801
treatment reduces Kv1.1 expression (Figure 6C), the fraction of
current that leaks during whole-cell patch clamp is minimized,
increasing the rate of membrane depolarization, and minimizing
first-spike latency (Figure 6D). This interpretation is further
supported by the finding that the resting input resistance (Rin) of
FSIs from MK-801-treated mice is 50% higher than FSIs from
vehicle-treated mice (Table 1) (P,0.01). Moreover, the amplitude
of Ith in FSIs from MK-801-treated mice was smaller than vehicletreated mice, although the difference did not reach statistical
significance (Table 1). Together, these data support our interpretation that first-spike latency is shortened in FSIs from MK-801–
treated mice because of reduced expression of the Kv1.1 subunit.

Neonatal MK-801-treatment May Increase the Spike
Threshold Dynamics of FSIs
Compared to FSIs from vehicle-treated mice, the spike
threshold of FSIs from MK-801-treated mice is more dynamic
and inversely correlated to stimulus intensity (Figure 2G, H).
During periods of sustained or intense stimulation the spike
threshold of FSIs from MK-801-treated mice could adapt to more
depolarized values [46] and thereby reduce excitability. Interestingly, FSIs from MK-801-treated mice exhibit a reduced
maximum spike rate and an increased spike accommodation ratio
(Table 1). Increased spike-threshold dynamics may help explain
these findings. It is not clear how neonatal MK-801 treatment
might increase the spike-threshold dynamics of FSIs. However, K+
channels comprised from the Kv1.1 subunit have been shown to
regulate spike-threshold variability [31,34,44]. Thus it is conceivable that the changes in FSI spike-threshold dynamics could result
from changes in the expression and/or function of K+ channels
comprised from the Kv1.1 subunit.

Neonatal MK-801 Treatment May Impair Physiological
Maturation of Neocortical FSIs
Our mechanistic model of how neonatal MK-801 treatment
shortens first-spike latency was derived from a relatively straightforward interpretation of our results. However, a more expansive
consideration of our findings supports the notion that neonatal
MK-801 treatment may broadly impair physiological maturation
of FSIs. Below we consider this idea within the context of our most
salient findings–disrupted membrane properties, shortened firstspike latency, and increased GluN2B NMDA current.
The membrane properties and spiking characteristics of mature
FSIs are highly specialized to facilitate the discharge of brief,
precisely timed spikes. Specifically, spikes from mature FSIs
exhibit a narrow spike width, low input resistance, fast membrane
time constant, and low frequency accommodation ratio [47] [32]
[33]. Curiously, these properties are not innately optimized, but
rather undergo extensive refinement during the postnatal development of FSIs. For example, FSIs from immature mice have a
high input resistance, slow membrane time constant, broad spike
width and exhibit considerable spike frequency accommodation

Discussion
Here we demonstrate that neonatal MK-801 treatment disrupts
both intrinsic and synaptic functions of neocortical FSIs in
adolescent mice. These findings support our hypothesis that
transient neonatal NMDA receptor blockade causes persistent
alterations in FSI physiology, and we now propose a mechanism
by which these alterations could be mediated.
PLOS ONE | www.plosone.org
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[33]. These immature features oppose the rapid and precise
spiking activity that characterizes mature FSIs [47]. However,
FSIs undergo rapid postnatal development, and by P18 they attain
mature membrane properties and spiking characteristics that
remain stable through adulthood [30].
In this study the membrane properties and spiking characteristics of FSIs were evaluated in adolescent mice aged adolescent
mice aged PND 2662.3. Notably, several of the membrane
properties and spiking characteristics of FSIs from MK-801
treated mice were physiologically immature compared to FSIs
from age-matched, vehicle-treated mice. For instance, the average
membrane resistance and spike accommodation ratio of FSIs from
MK-801-treated mice were significantly less mature than FSIs
from vehicle-treated mice (Table 1). Similarly, the membrane time
constant (tm), steady-state firing rate, and instantaneous firing rate
of FSIs from MK-801-treated mice were also less mature than
FSIs from vehicle-treated mice (Table 1), though these differences
did not reach statistical significance. Overall, the membrane
properties and spiking characteristics of FSIs from MK-801treated mice exhibited a level of physiological maturity comparable to FSIs from healthy mice aged ,P13–15 [30]. We therefore
conclude that transient, neonatal MK-801 treatment impairs
biophysical maturation of neocortical FSIs. More broadly, these
data suggest a role for NMDA signaling in the normal
development of FSIs.

[49,50]. During adolescence a stereotyped developmental switch
occurs and the proportion of NMDA current mediated by
GluN2B-containing receptors in FSIs diminishes [24]. Thus, the
proportion of GluN2B-mediated NMDA current is approximately
inversely proportional to FSI development. In this study NMDA
current was characterized from the FSIs of adolescent mice (PND
42–45). Sensitivity to the GluN2B-specific antagonist, ifenprodil,
was used to determine the contribution of GluN2B-mediated
NMDA current. As expected, NMDA current evoked from the
FSIs of vehicle-treated mice was comprised of only 35% GluN2Bmediated current, whereas NMDA current evoked from the FSIs
of MK-801-treated mice was comprised of about 90% GluN2Bmediated current (Figures 5T–Z). While this study was in progress
two reports emerged which corroborate our findings. In the first
report, neonatal administration of a GluN2A-specific antagonist
increased the proportion of GluN2B-mediated NMDA current
evoked from FS cells in the somatosensory cortex of adolescent
mice [24]. In the second report, perinatal administration of
phencyclidine increased the expression of the GluN2B subunit in
the prefrontal cortex of adolescent rats [51]. Together, these data
suggest transient disruption of NMDA signaling may indelibly
alter the ontogeny of excitatory synapses throughout the neocortex.
In summary, neonatal NMDA receptor blockade remains a
robust approach for modeling many schizophrenia-like behavioral
deficits in animals [17]. However, the pathophysiological mechanisms which give rise to the behavioral deficits are unclear. In this
study we discovered that neonatal NMDA receptor blockade
simultaneously minimizes first-spike latency and increases the
proportion of GluN2B-mediated NMDA current at thalamocortical synapses onto neocortical FSIs. Both of these results are
consistent with our general notion that neonatal MK-801
treatment impairs the physiological maturation of neocortical
FSIs, and since layer IV FSIs process the majority of thalamic
sensory input, it is conceivable that the disturbances in FSI
physiology we report contribute to the pathophysiology underlying
the schizophrenia-like behaviors.

Neonatal MK-801 Treatment May Impair Developmental
Regulation of First-Spike Latency
FSIs can be distinguished by first-spike latency [48], but the
development of this pattern has not been fully characterized.
However, since first-spike latency is highly dependent on the
Kv1.1 subunit (Goldberg et al 2008), it is likely to correlate with
the developmental expression of the Kv1.1 subunit. In neonatal
mice the expression of Kv1.1 mRNA is very low in neocortical
FSIs, but the expression increases more than 40-fold by P21 [33].
If expression of the Kv1.1 subunit is monotonically regulated, firstspike latency in FSIs may progress with a similar developmental
trajectory. If so, our finding that transient, neonatal MK-801
treatment reduces expression of the Kv1.1 subunit and shortens
first-spike latency in the FISIs of adolescent mice further supports
the notion that NMDA signaling contributes to the physiological
development of neocortical FSIs.
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